Almac building facility in Ireland

Almac Group is building a new facility in Ireland as part of its ongoing expansions.

Just weeks after announcing plans to expand and add jobs in the U.S., CDMO Almac is doing the same in Ireland. Almac will build a new facility in Dundalk, County Louth, near the border with its home country of Northern Ireland.

Almac announced today that it will make a multimillion-euro investment at an Ireland Development Authority business park. It is getting some support for Ireland’s Department of Jobs. The  company offered few details but said the new 32,000-square-foot facility will be used by its pharma and clinical services units.

Almac, which has been steadily expanding for several years, laid out a multiproject blueprint in November to make small investments in a number of its facilities, as well as a significant expansion to its U.S. headquarters.

Free Webinar

Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This webinar will discuss the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

The company is spending $25 million (£20 million) to expand its 240,000-square-foot offices at its U.S. headquarters in Souderton, Pennsylvania, and to lease a 26,000-square-foot office space in nearby Lansdale. The drug services company is getting about $1.6 million in state support for the project and has committed to adding 312 jobs.

At the time, it also said it would invest about $2.5 million (£2 million) to upgrade facilities at the Arran Chemical Company facility in Athlone, Ireland that it bought last year. Almac is investing another $6.3 million (£5 million) to build an additional laboratory and office facility at its global headquarters in Craigavon, Northern Ireland. The company said about 170 existing employees will move to the new facility.

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.